Healthcare Reform Called Vital to Secure Thailand’s Economic Future
Rapid population ageing threatens Thailand's economic growth, prompting urgent calls for early disease care and sustainable healthcare financing.
- Healthcare reform is deemed vital for Thailand's economy due to a rapidly aging population and a projected 30% reduction in the active workforce by 2060.
- The proposed reform advocates shifting from costly late-stage disease treatment to a focus on early intervention, screening, and prevention to keep the workforce healthy and productive longer.
- A five-year strategic model aims to secure the economic future through sustainable healthcare financing and a collaborative "Team Thailand" platform to attract R&D investment and boost competitiveness.
Thailand is approaching a critical demographic turning point as a rapidly ageing population threatens long-term economic stability.
The World Bank estimates that the country’s working-age population share will shrink from 71% in 2020 to 56% by 2060, reducing the active workforce by nearly 30%. In response, healthcare and policy experts are urging the Thai government to reposition health from a fiscal burden to a strategic investment in national competitiveness.
Against this backdrop, Mr. Harald Sprenger, Chief Executive Officer of Pharmaceutical Research and Manufacturers Association (PReMA), is calling for health to be placed firmly on Thailand’s national economic agenda.
Healthcare, he said, should no longer be viewed merely as a fiscal burden, but as a long-term investment in human capital, quality of life and national competitiveness.
“We are not talking about asking the government to spend more. We are talking about spending more wisely,”
“If Thailand can detect diseases earlier, begin treatment sooner and prevent illnesses from progressing, the country can substantially reduce its long-term costs.”
Late treatment carries a hidden economic cost
One of the most urgent weaknesses in Thailand’s healthcare system is that treatment often begins only after diseases have progressed to an advanced stage, particularly in cases involving noncommunicable diseases such as cancer, cardiovascular disease and diabetes.
“The biggest problem is that treatment in Thailand often begins when diseases have already progressed too far,” Mr. Sprenger said.
“Late-stage treatment is not only less likely to succeed than early treatment; it is also more costly for patients, families and the wider economy.”
The economic cost of poor health extends far beyond hospital bills. When older family members become seriously ill, working-age relatives are often forced to take leave or temporarily withdraw from the labour market to provide care.
Businesses consequently lose productive employees, households lose income and the country loses economic opportunities.
Strong family ties remain one of Thailand’s social strengths,Mr.Sprenger said, but the responsibility of providing care can significantly affect the productivity of younger generations.
Keeping older people healthy and independent for longer would allow more working-age Thais to remain economically active, while reducing pressure on families and the public healthcare system.
Delayed treatments for noncommunicable diseases (NCDs) - such as cancer, cardiovascular conditions, and diabetes - carry severe hidden costs.
Beyond direct medical bills, chronic illnesses force working-age relatives out of the labor market to provide care, dampening overall national productivity.
To mitigate these structural risks, a five-year strategic model centered on three core priorities has been proposed:
1. Early Intervention and Prevention
Transitioning public health policy away from high-cost, late-stage disease management toward early screening, diagnosis, and adult vaccination keeps the workforce healthy and independent longer.
2. Sustainable Healthcare Financing
To balance patient access with public budget limits, healthcare leaders advocate for Managed Entry Agreements (MEAs), price-volume arrangements, and a defined role for supplementary health insurance to share financial risks without compromising universal care.
3. "Team Thailand" Collaborative Platform
The initiative calls for dismantling administrative silos among regulatory agencies, universities, hospitals, and private industry.
Streamlining data connectivity and leveraging AI for regulatory processes will accelerate approval timelines and attract global R&D investment.
Furthermore, expanding clinical trial capabilities beyond Bangkok to regional university hospitals will strengthen national research capacity.
Connecting health policy with regulatory efficiency will enable Thailand to transform its demographic challenges into economic opportunities, cementing its position as Asia's premier biotechnology and life-sciences hub.
